SCHEMBL6893318

SCHEMBL6893318

COc1cc(CNCC(O)C(Cc2ccccc2)NC(=O)O)cc(OC)c1

nearest known ligand 0.67

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.66
CTSD P07339 10/20 0.63
BACE1 P56817 13/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7611423 1.00 BCHE (0.66) BCHECTSDBACE1
SCHEMBL7611436 1.00 BCHE (0.66) BCHECTSDBACE1
SCHEMBL6896962 0.92 BCHE (0.77) BCHECTSDBACE1
SCHEMBL3354210 0.92 BCHE (0.77) BCHECTSDBACE1
SCHEMBL3354218 0.92 BCHE (0.77) BCHECTSDBACE1
SCHEMBL3510079 0.92 BCHE (0.77) BCHECTSDBACE1
SCHEMBL3509752 0.91 BACE1 (0.59) BCHECTSDBACE1
SCHEMBL3509758 0.91 BACE1 (0.59) BCHECTSDBACE1
SCHEMBL3509756 0.91 BACE1 (0.59) BCHECTSDBACE1
SCHEMBL5450473 0.89 BCHE (0.61) BCHECTSDBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004502669-A 2004-01-29 JP claimed
EP-1353898-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2003-10-22 EP claimed
WO-2002002512-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 WO claimed